Cell-mediated immunity to insulin: A new criterion for differentiation of diabetes mellitus?

Medical Hypotheses

Volumn 78, Issue 3, 2012, Pages 402-406

  Asfandiyarova, Nailya S ^a  

^a RYAZAN STATE MEDICAL UNIVERSITY   (Russian Federation)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; HISTAMINE; HISTAMINE H2 RECEPTOR ANTAGONIST; HISTAMINE RECEPTOR; INSULIN; INSULIN ANTIBODY; NONSTEROID ANTIINFLAMMATORY AGENT; PROSTAGLANDIN;

ANTIBODY RESPONSE; ARTICLE; AUTOIMMUNITY; CELLULAR IMMUNITY; DIABETES MELLITUS; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN RESISTANCE; NON INSULIN DEPENDENT DIABETES MELLITUS; PANCREAS ISLET BETA CELL; PREGNANCY DIABETES MELLITUS; PROSTAGLANDIN SYNTHESIS; VIRUS IMMUNITY; VIRUS INFECTION; VIRUS VIRULENCE;

DIABETES MELLITUS; HUMANS; IMMUNITY, CELLULAR; INSULIN RESISTANCE; MODELS, IMMUNOLOGICAL; PARAMYXOVIRIDAE INFECTIONS;

PARAMYXOVIRIDAE;

EID: 84856422887     PISSN: 03069877     EISSN: 15322777     Source Type: Journal    
DOI: 10.1016/j.mehy.2011.11.018     Document Type: Article

References (62)

1. Mayfield J. Diagnosis and classification of diabetes mellitus: new criteria. Am Fam Physician 1998, 58:1352-1369.
2. World Health Organization: definition, diagnosis and classification of diabetes mellitus and its complications. Report of a WHO consultation. Part 1: diagnosis and classification of diabetes mellitus. Geneva: World Health Org.; 1999.
3. Shaw J.E., Zimmet P.Z., McCarty D., de Courten M. Type 2 diabetes worldwide according to the new classification and criteria. Diabetes Care 2000, 23(Suppl. 2):B5-B10.
4. Report of the expert committee on the diagnosis and classification of diabetes mellitus. Diabetes Care 2003, 26(Suppl. 1):S5-S20. The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus.
5. Diagnosis and classification of diabetes mellitus. Diabetes Care 2004, 27:S5-S10. American Diabetes Association.
6. Diagnosis and classification of diabetes mellitus. Diabetes Care 2005, 28:S37-S42. American Diabetes Association.
7. Diagnosis and classification of diabetes mellitus. Diabetes Care 2006, 29:S43-S48. American Diabetes Association.
8. Di Mario U., Irvine W.J., Borsey D.Q., Kyner J.L., Weston J., Galfo C. Immune abnormalities in diabetic patients not requiring insulin at diagnosis. Diabetologia 1983, 25:392-395.
9. Turner R., Stratton I., Horton V., Manley S., Zimmet P., Mackay I.R., et al. UKPDS 25: auto antibodies to islet-cell cytoplasm and glutamic acid decarboxylase for prediction of insulin requirement in type 2 diabetes. Lancet 1997, 350:1288-1293.
10. Pozzilli P., Di Mario U. Autoimmune diabetes not requiring insulin at diagnosis (latent autoimmune diabetes of the adult). Diabetes Care 2001, 24:1460-1467.
11. Falorni A., Brozzetti A. Diabetes-related antibodies in adult diabetic patients. Best Pract Res Clin Endocrinol Metab 2005, 1:119-133.
12. Asfandiyarova N.S., Shatrov V.V., Goncharenko L.V., Kolcheva N.G. Immune system in elderly and old persons (in Russian). Klin Gerontol 1996, 4:25-28.
13. Asfandiyarova N.S., Kolcheva N.G., Shatrova I.V., Goncharenko L.V. Comparative immunopathology of diabetes mellitus (in Russian). Probl Endocrinol 1998, 6:3-5.
14. Asfandiyarova N.S., Kolcheva N.G., Shatrova I.V. About heterogeneity of diabetes mellitus (in Russian). Ter Arch 1999, 12:49-52.
15. Asfandiyarova N.S., Ryazantsev I.V., Ryazantsev V.S. Cell-mediated immunity against insulin in stroke (in Russian). Zurnal Neuropathol Psyhiatr (Suppl. Stroke) 2004, 12:66-71.
16. Asfandiyarova N.S., Kolcheva N.G., Ryazantsev I.V., Ryazantsev V.S. Risk factors for stroke in type 2 diabetes mellitus. Diabetes Vasc Dis Res 2006, 3:57-60.
17. Asfandiyarova N.S., Shishova T.I., Kuznetsov V.F., Bunova N.N., Mulina N.A., Ignatiev V.A., et al. Cell-mediated immunity to insulin is one of the risk factors for ischemic heart disease (in Russian). Kardiologija 2007, 3:14-18.
18. Asfandiyarova NS. Immunological diagnosis for pre-diabetes. In: International symposium: physiology of immune system. Perspective attach to diagnosis and therapy of immunopathology and allergic diseases. Moscow; 2006. p. 19 [abstr].
19. Asfandiyarova N.S. Prolonged cellular immunity to viral antigens (mumps, measles) in diabetes mellitus (abstr). Allergy 2003, 58(Suppl. 74):377.
20. Asfandiyarova N.S., Shatrov V.V., Garipov G.K. Cell-mediated immunity to viral antigens family Paramyxoviridae (mumps, measles) in diabetes mellitus (in Russian). Probl Endocrinol 2006, 6:18-21.
21. Asfandiyarova N.S. Cell-mediated immunity to insulin as risk factor for diabetes mellitus development (in Russian). Ter Arch 2009, 11:56-59.
22. Asfandiyarova N.S. Ranitidin and indometacin in the treatment of insulin resistance (abstr). Diabetes Vasc Dis Res 2004, 1:138.
23. Pickup J.C. Inflammation and activated innate immunity in the pathogenesis of type 2 diabetes. Diabetes Care 2004, 27:813-823.
24. Sjoholm A., Nystrom T. Endothelial inflammation in insulin resistance. Lancet 2005, 12:610-612.
25. Fernández-Real J.-M., López-Bermejo A., Vendrell J., Ferri M.-J., Recasens M., Ricart W. Burden of infection and insulin resistance in healthy middle-aged men. Diabetes Care 2006, 29:1058-1064.
26. Asfandiyarova N.S., Shatrova I.V., Kolcheva J.G. Immunocorrective therapy in cardio vascular diseases prophylaxis in patients with type 2 diabetes mellitus (in Russian). Allergol Immunol 2006, 3:409.
27. Hundal R.S., Petersen K.F., Mayerson A.B., et al. Mechanism by which high dose aspirin improves glucose metabolism in type 2 diabetes. J Clin Invest 2002, 109(10):1321-1326.
28. Harris M.I., Eastman R.C. Early detection of undiagnosed diabetes mellitus: a US perspective. Diab Metab Res Rev 2000, 16(4):230-236.
29. Deedwania P.C., Fonseca V.A. Diabetes, prediabetes, and cardiovascular risk: shifting the paradigm. Am J Med 2005, 118(9):939-947.
30. Park K.S. Prevention of type 2 diabetes mellitus from the viewpoint of genetics. Diabetes Res Clin Pract 2004, 66(Suppl. 1):S33-S35.
31. Facchini F.S., Hua N., Abbasi F., Reaven G.M. Insulin resistance as a predictor of age-related diseases. J Clin Endocrinol Metab 2001, 86(8):3574-3578.
32. Gillespie K.M. Type 1 diabetes: pathogenesis and prevention. CMAJ 2006, 175(2):165-170.
33. Hyoty H. Enterovirus infections and type 1 diabetes. Ann Med 2002, 34:138-147.
34. Honeyman M.C., Coulson B.C., Stone N.L., et al. Association between rotavirus infection and pancreatic islet autoimmunity in children at risk of developing type 1 diabetes. Diabetes 2000, 49:1319-1324.
35. Ginsberg-Fellner F., Witt M.E., Fedun B., et al. Diabetes mellitus and autoimmunity in patients with the congenital rubella syndrome. Rev Infect Dis 1985, 7(Suppl 1):S170-S176.
36. Peltola H., Davidkin I., Paunio L., et al. Mumps and rubella eliminated from Finland. JAMA 2000, 284:2643-2647.
37. Viskari H., Ludvigsson J., Uibo R., et al. Relationship between the incidence of type 1 diabetes and maternal enterovirus antibodies: time trends and geographical variation. Diabetologia 2005, 48:1280-1287.
38. Baekkeskov S., Warnock J., Christie M., et al. Revelation of specificity of 64 K autoantibodies in IDDM serums by high-resolution 2-D gel electrophoresis. Unambiguous identification of 64 K target antigen. Diabetes 1989, 38:1133-1141.
39. Lan M.S., Wasserfall C., Maclaren N.K., et al. IA-2 a transmembrane protein of the protein tyrosine phosphatase family, is a major autoantigen in insulin-dependent diabetes mellitus. Proc Natl Acad Sci USA 1996, 25(93):6367-6370.
40. Palmer J.P. Insulin autoantibodies: their role in the pathogenesis of IDDM. Diabetes Metab Rev 1987, 3:1005-1015.
41. Verge C.F., Stenger D., Bonifacio E., et al. Combined use of autoantibodies (IA-2 autoantibody, GAD autoantibody, insulin autoantibody, cytoplasmic islet cell antibodies) in type 1 diabetes: Combinatorial Islet Autoantibody Workshop. Diabetes 1998, 47:1857-1866.
42. Roivanen M., Ylipaasto P., Savolainen S., et al. Functional impairment and rilling of human beta cells by enteroviruses: the capacity is shared by a wide range of serotypes, by the extent is a characteristic of individual virus strains. Diabetologia 2002, 45:693-702.
43. Jones D.B., Crosby I. Proliferative lymphocyte responses to virus antigens homologous to GAD 65 in IDDM. Diabetologia 1996, 39(11):1318-1324.
44. Ou D., Mitchell L.A., Metzger D.L., et al. Cross-reactive rubella virus and glutamic acid decarboxylase (65 and 67) protein determinants recognized by T cells of patients with 1 type diabetes mellitus. Diabetologia 2000, 43(6):62-75.
45. Chen K.W., Boyko E.J., Bergstrom R.W., et al. Earlier appearance of impaired insulin secretion than of visceral adiposity in the pathogenesis of NIDDM. 5-year follow up of initially nondiabetic Japanese-American man. Diabetes Care 1995, 18(6):747-753.
46. Haffner S.M., Miettinen H., Gaskill S.P., Stern M.P. Decreased insulin secretion and increased insulin resistance are independently related to the 7-year risk of NIDDM in Mexican-Americans. Diabetes 1995, 44(12):1386-1391.
47. Weyer C., Bogardus C., Mott DM Pratley R.E. The natural history of insulin secretory dysfunction and insulin resistance in the pathogenesis of type 2 diabetes mellitus. J Clin Invest 1999, 104(6):787-794.
48. Saad M.F., Knowler W.C., Pettitt D.J., et al. Sequential changes in serum insulin concentration during development of non-insulin-dependent diabetes. Lancet 1989, 1:1356-1359.
49. Weyer C., Tataranni P.A., Bogardus C., Pratley R.E. Insulin resistance and insulin secretory dysfunction are independent predictors of worsening of glucose tolerance during each stage of type 2 diabetes development. Diabetes Care 2000, 24:89-94.
50. Reaven G.M., Hollenbeck C.B., Chen Y.D.I. Relationship between glucose tolerance, insulin secretion, and insulin action in non-obese individuals with varying degrees of glucose tolerance. Diabetologia 1989, 32:52-55.
51. Martin B.C., Warram J.H., Krolewski A.S., et al. Role of glucose and insulin resistance in development of type 2 diabetes mellitus: results of a 25-year follow-up study. Lancet 1992, 340:925-929.
52. Lillioja S., Mott D.M., Spraul M., et al. Insulin resistance and insulin secretory dysfunction as precursors of non-insulin-dependent diabetes mellitus. N Engl J Med 1993, 329:1988-1992.
53. Yuhua Sun, Weidong Pei, Yongjin Wu, Yuejin Yang An association of herpes simplex virus type 1 infection with type 2 diabetes. Diabetes Care 2005, 28:435-436.
54. Lecube A., Hernandez K., Genesca J., Simo R. Proinflammatory cytokines, insulin resistance, and insulin secretion in chronic hepatitis C patients. Diabetes Care 2006, 29:1096-1101.
55. Roberts B.W., Cech I. Association of type 2 diabetes mellitus and seroprevalence for cytomegalovirus. South Med J 2005, 98(7):686-692.
56. Dhurandhar N.V., Atkinson R.L. Viruses and obesity. Curr Opin Endocrinol Diab Obesity 2000, 7(5):24-35.
57. Dussoix P., Vaxillaire M., Iynedjian P.B., et al. Diagnostic heterogeneity of diabetes in lean young adults: classification based on immunological and genetic parameters. Diabetes 1997, 46(4):622-631.
58. Unnikrishnan A.G., Singh S.K., Sanjeevi C.B. Prevalence of GAD 65 antibodies in lean subjects with type 2 diabetes. Ann N Y Acad 2004, 1037:118-121.
59. Falorni A., Brozzetti A. Diabetes- related antibodies in adult diabetic patients. Best Pract Res Clin Endocrinol Metab 2005, 19(1):119-133.
60. Orchard T.J., Olson J.S., Erbey J.R., et al. Insulin resistance - related factors, but not glycemia, predict coronary artery disease in type 1 diabetes. Diabetes Care 2003, 26:1374-1379.
61. Brooks-Worrell B.M., Greenbaum C.J., Palmer J.P., Pihoker C. Autoimmunity to islet proteins in children diagnosed with new- onset diabetes. J Clin Endocrinol Metab 2004, 89(5):2222-2227.
62. Hoekstra J.B., de Koning E.J. Diabetes mellitus, but which type?. Ned Tijdschr Geneeskd 2004, 148(16):761-764.